| Serial Number | 79143546 |
| Word Mark | B PURUI |
| Filing Date | Thursday, November 28, 2013 |
| Status | 404 - IR CANCELLED - US REGISTRATION CANCELLED |
| Status Date | Monday, November 27, 2023 |
| Registration Number | 4634904 |
| Registration Date | Tuesday, November 11, 2014 |
| Mark Drawing | 3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s) |
| Published for Opposition Date | Tuesday, August 26, 2014 |
| Description of Mark | The mark consists of the name "PURUI" located beneath the letter "b" inside a geometric design above a chevron. |
| Goods and Services | Pharmaceutical preparations in injection, tablet, and liquid for treating allergic rhinitis and asthma, diabetes, skin disorders, allergies, hypertension; Chinese Medicine in the nature of medicinal herbs; Medicinal alcohol; Pesticides; Hormones, namely, Eplerenone for treating hypertension; Fluticasone Propionate for preventing and treating allergic rhinitis; topical corticosteroid preparations, namely, diflucortolone for topical corticosteroids anti-inflammatory; Deflazacort for treating adrenal cortical hypofunction, autoimmune disease, allergic diseases and diseases of the blood system, Betamethasone for treating allergic and autoimmune inflammatory diseases, active rheumatism, rheumatoid arthritis, lupus erythematosus, severe bronchial asthma, severe dermatitis, and acute leukemia; Dexamethasone for treating autoimmune diseases, allergy, inflammation, asthma and ophthalmology disease; Dexamethasone for treating Inflammatory and allergic diseases; Dexamethasone sodium phosphate for treating fever, 6-methyl prednisolone for treating inflammation; steroid hormones, namely, cortisol for treating adrenal insufficiency, arthritis pauperum, rheumatic fever, arthrolithiasis, bronchial asthma, allergic dermatitis, seborrheic dermatitis, pruritus, iridocyclitis, conjunctivitis, keratitis, scleritis, tuberculous meningitis, arthritis, pleurisy, tenosynovitis, acute and chronic sprain, and tendon strain; Hydrocortisone Acetate for treating rheumatic arthritis, acute articular rheumatism, arthrolithiasis, bronchial asthma, tuberculous, purulent meningitis, tuberculous pleurisy, pyothorax, arthritis, peritendinitis, sprain, hyde's disease, and lichen planus; Medroxyprogesterone Acetate for treating algomenorrhea, functional amenorrhea, dysfunctional uterine bleeding, threatened abortion and habitual abortion, endometriosis uterine, mammary cancer, adenocarcinoma of endometrium, and renal carcinoma; Cyproterone Acetate for treating prostatic carcinoma, hirsutism, and androgenetic alopecia; Prednisolone for treating allergic and inflammatory diseases; Prednisolone Acetate for treating dermatitis, eczema, lichen planus circumscriptus, seborrheic dermatitis, rheumatism, arthritis deformans, Biett's disease, bronchial asthma, dropsical nephritis, essential thrombopenia, granulocytopenia, acute lymphatic leukemia, adrenal insufficiency, and dermatitis exfoliativa; Astenile for treating advanced cervix mature insufficiency; Trenbolone Acetate for treating chronic wasting disease, ill and frail thin, frail after operation, osteoporosis, children dysplasia, and aplastic anemia; Stanazolol for treating hereditary angioneurotic edema, and cacotrophy; Oxymetholone for treating chronic wasting disease, infirm, sick and postoperative weak thin, nausea, edema, liver dysfunction and jaundice; Estradiol for treating estrogen deficiency, metastatic breast cancer, advanced prostate cancer, acne, aleucocytosis, and postcoital contraception; Estriol for treating cervicitis, auxiliary medicine and abortion of midtrimester induction of labor, prostatauxe, prostatic carcinoma, aleucocytosis, and haemorrhage |
| Indication of Colors claimed | Color is not claimed as a feature of the mark. |
| Translation of Words in Mark | The wording "PURUI" has no meaning in a foreign language. |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 006, 018, 044, 046, 051, 052 |
| Class Status Code | F - NOT AVAILABLE |
| Class Status Date | Friday, May 28, 2021 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | Zhejiang Pure Pharmaceutical Co., Ltd. |
| Party Type | 30 - Original Registrant |
| Legal Entity Type | 99 - Other |
| Address | CN |
| Party Name | Xianju Pure Pharmaceutical Co., Ltd |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 99 - Other |
| Address | Xianju, Zhejiang CN |
| Party Name | Xianju Pure Pharmaceutical Co., Ltd |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 99 - Other |
| Address | Xianju, Zhejiang CN |
| Event Date | Event Description |
| Thursday, March 13, 2014 | NON-FINAL ACTION WRITTEN |
| Friday, March 14, 2014 | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB |
| Friday, April 4, 2014 | REFUSAL PROCESSED BY IB |
| Thursday, March 6, 2014 | SN ASSIGNED FOR SECT 66A APPL FROM IB |
| Saturday, March 8, 2014 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Wednesday, March 12, 2014 | APPLICATION FILING RECEIPT MAILED |
| Thursday, March 13, 2014 | ASSIGNED TO EXAMINER |
| Friday, March 14, 2014 | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW |
| Friday, March 14, 2014 | REFUSAL PROCESSED BY MPU |
| Tuesday, July 15, 2014 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Friday, June 6, 2014 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Monday, June 16, 2014 | ASSIGNED TO LIE |
| Friday, June 27, 2014 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Friday, June 27, 2014 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Friday, July 11, 2014 | FINAL REFUSAL WRITTEN |
| Friday, July 11, 2014 | FINAL REFUSAL E-MAILED |
| Friday, July 11, 2014 | NOTIFICATION OF FINAL REFUSAL EMAILED |
| Tuesday, July 15, 2014 | TEAS REQUEST FOR RECONSIDERATION RECEIVED |
| Wednesday, July 16, 2014 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Wednesday, August 6, 2014 | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB |
| Tuesday, November 11, 2014 | REGISTERED-PRINCIPAL REGISTER |
| Thursday, July 17, 2014 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, July 23, 2014 | LAW OFFICE PUBLICATION REVIEW COMPLETED |
| Wednesday, August 6, 2014 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Wednesday, August 6, 2014 | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB |
| Friday, August 22, 2014 | NOTIFICATION PROCESSED BY IB |
| Tuesday, August 26, 2014 | PUBLISHED FOR OPPOSITION |
| Tuesday, August 26, 2014 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Friday, May 28, 2021 | CANCELLED SECTION 71 |
| Friday, January 28, 2022 | TOTAL INVALIDATION OF REG EXT PROTECTION CREATED |
| Wednesday, February 11, 2015 | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB |
| Monday, April 6, 2015 | FINAL DISPOSITION PROCESSED |
| Monday, April 6, 2015 | FINAL DISPOSITION NOTICE SENT TO IB |
| Friday, April 24, 2015 | FINAL DECISION TRANSACTION PROCESSED BY IB |
| Thursday, November 17, 2016 | CHANGE OF NAME/ADDRESS REC'D FROM IB |
| Monday, November 11, 2019 | COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED |
| Monday, May 23, 2022 | GENERIC MADRID TRANSACTION CREATED |
| Tuesday, May 24, 2022 | GENERIC MADRID TRANSACTION SENT TO IB |
| Monday, July 11, 2022 | TOTAL INVALIDATION PROCESSED BY THE IB |
| Sunday, June 23, 2024 | DEATH OF INTERNATIONAL REGISTRATION |
| Sunday, June 23, 2024 | NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED |